Business Description
National Research Corp
NAICS : 923120
SIC : 7372
1245 Q Street, Lincoln, NE, USA, 68508
Description
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. The solutions are offered at an enterprise level through the Voice of the Customer platform, The Governance Institute, and legacy Experience solutions. It operates in the US and Canada, of which key revenue is derived from the US.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.35 | |||||
| Equity-to-Asset | 0.5 | |||||
| Debt-to-Equity | 0.36 | |||||
| Debt-to-EBITDA | 0.45 | |||||
| Interest Coverage | 34 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 10.03 | |||||
| Beneish M-Score | -2.52 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 10.6 | |||||
| 3-Year EBITDA Growth Rate | 14.2 | |||||
| 3-Year EPS without NRI Growth Rate | 12 | |||||
| 3-Year FCF Growth Rate | 9.7 | |||||
| 3-Year Book Growth Rate | 63.6 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 52.06 | |||||
| 9-Day RSI | 46.68 | |||||
| 14-Day RSI | 46.5 | |||||
| 6-1 Month Momentum % | -6.41 | |||||
| 12-1 Month Momentum % | -29.97 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.31 | |||||
| Quick Ratio | 1.31 | |||||
| Cash Ratio | 0.83 | |||||
| Days Sales Outstanding | 35.19 | |||||
| Days Payable | 7.81 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.02 | |||||
| Dividend Payout Ratio | 0.51 | |||||
| 3-Year Dividend Growth Rate | -8.7 | |||||
| Forward Dividend Yield % | 2.7 | |||||
| 5-Year Yield-on-Cost % | 2.05 | |||||
| 3-Year Average Share Buyback Ratio | -0.7 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 62.84 | |||||
| Operating Margin % | 32.41 | |||||
| Net Margin % | 23.82 | |||||
| ROE % | 45.76 | |||||
| ROA % | 23.94 | |||||
| ROIC % | 34.86 | |||||
| ROC (Joel Greenblatt) % | 367.83 | |||||
| ROCE % | 44.26 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 24.83 | |||||
| PE Ratio without NRI | 24.83 | |||||
| Shiller PE Ratio | 34.1 | |||||
| Price-to-Owner-Earnings | 27.31 | |||||
| PEG Ratio | 2.7 | |||||
| PS Ratio | 5.96 | |||||
| PB Ratio | 12.83 | |||||
| Price-to-Tangible-Book | 163.95 | |||||
| Price-to-Free-Cash-Flow | 28.02 | |||||
| Price-to-Operating-Cash-Flow | 23.24 | |||||
| EV-to-EBIT | 17.77 | |||||
| EV-to-EBITDA | 16 | |||||
| EV-to-Revenue | 5.74 | |||||
| EV-to-FCF | 27.46 | |||||
| Price-to-Projected-FCF | 2.14 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.72 | |||||
| Price-to-Graham-Number | 13.66 | |||||
| Earnings Yield (Greenblatt) % | 5.63 | |||||
| Forward Rate of Return (Yacktman) % | 12.84 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Gurus Latest Trades with NAS:NRC
Executives
EMBED
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 151.798 | ||
| EPS (TTM) ($) | 1.43 | ||
| Beta | 0.84 | ||
| Volatility % | 29.04 | ||
| 14-Day RSI | 46.5 | ||
| 14-Day ATR ($) | 1.166561 | ||
| 20-Day SMA ($) | 36.8595 | ||
| 12-1 Month Momentum % | -29.97 | ||
| 52-Week Range ($) | 30.93 - 55.67 | ||
| Shares Outstanding (Mil) | 24.77 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
National Research Corp Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||